Market Access: MedTech

Mock Negotiations and Payer Consultations

Evaluating value using industry-leading standards

Alira Health provides mock negotiations and payer consultations in the MedTech industry to vet the value of a product from both the clinical, or provider, perspective as well as the economic, or payer perspective.

The Alira Health team can provide clear direction on these perspectives to determine pricing, considering the following key sections:
  • Product and unmet need
  • Understand objectives
  • Understand geographic scope
  • Number of advisors
  • Format: Blinded / Unblinded
  • Prepare advisors (pre-read)
  • Prepare company (roles and responsibilities)
  • Summarize day comments
  • Develop key insights for commercial team
  • Link to pricing/commercialization

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Access to a diverse

    integrated team with deep industry expertise

  • Close collaboration

    with our regulatory and clinical

  • Specific, local insights

    as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Richard Charter
Richard Charter
Vice President, Market Access, MedTech, Europe and Asia-Pacific
Our holistic, lifecycle approach to market access provides clients with maximum clinical and economic value for their technology while supporting patient-centered, value-based healthcare.

Related News

Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
Due Diligence MedTech Patient Engagement
Publications March 24, 2021
Drug Delivery Devices (DDD): Increasing Role in Patient Outcome and Future Trends, New England’s Global Appeal to Foster Collaboration
Download our newest report, Drug Delivery Devices (DDD): Increasing role in patient outcome and future trends, New England’s global appeal to foster collaboration. In this report,(...)
MedTech
News March 3, 2021
The 2021 MedTech Contract Manufacturing Report
Download our latest piece: The 2021 MedTech Contract Manufacturing Report. Learn how despite the ongoing pandemic, the Medical Device and CDMO industries are positioned to perform(...)
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Market Access MedTech
Publications December 5, 2020
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.